Singh L P, Gennerette D, Simmons S, Crook E D
Division of Nephrology, University of Mississippi Medical Center, 2500 North State Street, Jackson, MS 39216, USA.
J Diabetes Complications. 2001 Mar-Apr;15(2):88-96. doi: 10.1016/s1056-8727(00)00140-9.
Hyperglycemia is responsible for many of the vascular complications and metabolic derangements seen in diabetes. One potential regulator of the effects of glucose is the hexosamine biosynthesis pathway (HBP). Glutamine: fructose-6-phosphate amidotransferase (GFA), the first and rate-limiting enzyme in this pathway, catalyzes the transfer of an amino group from glutamine to fructose-6-phosphate to form glucosamine-6-phosphate. Overexpression of GFA in rat-1 fibroblasts results in insulin resistance for glycogen synthase (GS) activity, and renders these cells more sensitive to the effects of glucose. Using rat-1 cells, we examine further the mechanisms whereby hexosamines lead to insulin resistance. Insulin stimulated GS activity was found to occur via a PI-3 kinase (PI-3K)-dependent pathway as wortmannin, an inhibitor of PI-3K, blocked insulin's ability to stimulate GS activity. Subsequently, we examined the effects of hexosamines on PI-3K and Akt/PKB activity. Cells were cultured in 1 mM glucose (low glucose, LG), 20 mM glucose (high glucose, HG), or 1 mM glucose plus 3 mM glucosamine (GlcN) for 16--20 h. After treatment with insulin (100 nM) for 5 min, cell extracts were assayed for IRS-1 associated and total PI-3K activity. At LG, insulin increased PI-3K activity by 43%. There was no insulin stimulation of PI-3K activity in cells cultured in HG or GlcN. There was a trend for IRS-1 protein levels to decrease in HG but not GlcN. PI-3K protein levels were not altered by HG or GlcN. Finally PKB activity was assayed. At LG, insulin stimulated PKB activity. Again, both HG and GlcN significantly reduced insulin's ability to stimulate PKB activity. We conclude that the hexosamine-mediated insulin resistance of GS activity seen in rat-1 cells is mediated by hexosamine regulation of PI-3K and PKB.
高血糖是糖尿病中出现的许多血管并发症和代谢紊乱的原因。葡萄糖效应的一个潜在调节因子是己糖胺生物合成途径(HBP)。谷氨酰胺:果糖-6-磷酸酰胺转移酶(GFA)是该途径中的第一个限速酶,催化谷氨酰胺的氨基转移至果糖-6-磷酸以形成6-磷酸葡萄糖胺。在大鼠-1成纤维细胞中过表达GFA会导致糖原合酶(GS)活性出现胰岛素抵抗,并使这些细胞对葡萄糖的作用更敏感。利用大鼠-1细胞,我们进一步研究了己糖胺导致胰岛素抵抗的机制。发现胰岛素刺激GS活性是通过PI-3激酶(PI-3K)依赖性途径发生的,因为PI-3K抑制剂渥曼青霉素会阻断胰岛素刺激GS活性的能力。随后,我们研究了己糖胺对PI-3K和Akt/PKB活性的影响。将细胞培养在1 mM葡萄糖(低糖,LG)、20 mM葡萄糖(高糖,HG)或1 mM葡萄糖加3 mM葡萄糖胺(GlcN)中16 - 20小时。用胰岛素(100 nM)处理5分钟后,测定细胞提取物中与IRS-1相关的和总的PI-3K活性。在LG条件下,胰岛素使PI-3K活性增加了43%。在HG或GlcN培养的细胞中,胰岛素未刺激PI-3K活性。在HG条件下IRS-1蛋白水平有下降趋势,但在GlcN条件下没有。HG或GlcN未改变PI-3K蛋白水平。最后测定了PKB活性。在LG条件下,胰岛素刺激了PKB活性。同样,HG和GlcN均显著降低了胰岛素刺激PKB活性的能力。我们得出结论,大鼠-1细胞中所见的己糖胺介导的GS活性胰岛素抵抗是由己糖胺对PI-3K和PKB的调节介导的。